Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita

Yoshihiro Ito, Hiroko Kasai, Tetsuya Yoshida, Marwah A. Saleh, Masayuki Amagai, Jun Yamagami

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Epidermolysis bullosa acquisita (EBA) is an autoimmune subepidermal blistering disease caused by autoantibodies against type VII collagen. An enzyme-linked immunosorbent assay (ELISA) is currently available to detect autoantibodies in EBA. There have been reports suggesting generically that ELISA indices reflect EBA disease severity; however, there is, as yet, no conclusion as to whether ELISA indices fluctuate with disease activity over time in each EBA patient. This study aimed to investigate whether ELISA titers fluctuate with EBA disease activity and to validate the clinical significance of checking ELISA values in EBA by monitoring type VII collagen ELISA titers and disease severity, evaluated in terms of numbers of blisters and erosions as a clinical score, over time in three Japanese patients with EBA. All three cases in this study, which were treated successfully, showed titers of anti-type VII collagen autoantibodies detected by ELISA that fluctuated in parallel with disease activity. Especially in case 1, we could determine that the expanding erosions were not due to flare-ups of EBA because the ELISA indices stayed low, although new lesions continued to appear. In fact, control of infection and nutrition helped the lesions to become epithelialized. In conclusion, we found that repeated ELISA measurements are useful in monitoring disease activity and making decisions in EBA treatment plans.

Original languageEnglish
Pages (from-to)864-868
Number of pages5
JournalJournal of Dermatology
Volume40
Issue number11
DOIs
Publication statusPublished - 2013 Nov

Fingerprint

Epidermolysis Bullosa Acquisita
Collagen Type VII
Autoantibodies
Enzyme-Linked Immunosorbent Assay
Blister
Infection Control
Decision Making

Keywords

  • autoantibody
  • clinical severity
  • enzyme-linked immunosorbent assay
  • epidermolysis bullosa acquisita
  • type VII collagen

ASJC Scopus subject areas

  • Dermatology
  • Medicine(all)

Cite this

Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita. / Ito, Yoshihiro; Kasai, Hiroko; Yoshida, Tetsuya; Saleh, Marwah A.; Amagai, Masayuki; Yamagami, Jun.

In: Journal of Dermatology, Vol. 40, No. 11, 11.2013, p. 864-868.

Research output: Contribution to journalArticle

@article{58e3a88743ae4780a426412461f285c5,
title = "Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita",
abstract = "Epidermolysis bullosa acquisita (EBA) is an autoimmune subepidermal blistering disease caused by autoantibodies against type VII collagen. An enzyme-linked immunosorbent assay (ELISA) is currently available to detect autoantibodies in EBA. There have been reports suggesting generically that ELISA indices reflect EBA disease severity; however, there is, as yet, no conclusion as to whether ELISA indices fluctuate with disease activity over time in each EBA patient. This study aimed to investigate whether ELISA titers fluctuate with EBA disease activity and to validate the clinical significance of checking ELISA values in EBA by monitoring type VII collagen ELISA titers and disease severity, evaluated in terms of numbers of blisters and erosions as a clinical score, over time in three Japanese patients with EBA. All three cases in this study, which were treated successfully, showed titers of anti-type VII collagen autoantibodies detected by ELISA that fluctuated in parallel with disease activity. Especially in case 1, we could determine that the expanding erosions were not due to flare-ups of EBA because the ELISA indices stayed low, although new lesions continued to appear. In fact, control of infection and nutrition helped the lesions to become epithelialized. In conclusion, we found that repeated ELISA measurements are useful in monitoring disease activity and making decisions in EBA treatment plans.",
keywords = "autoantibody, clinical severity, enzyme-linked immunosorbent assay, epidermolysis bullosa acquisita, type VII collagen",
author = "Yoshihiro Ito and Hiroko Kasai and Tetsuya Yoshida and Saleh, {Marwah A.} and Masayuki Amagai and Jun Yamagami",
year = "2013",
month = "11",
doi = "10.1111/1346-8138.12278",
language = "English",
volume = "40",
pages = "864--868",
journal = "Journal of Dermatology",
issn = "0385-2407",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita

AU - Ito, Yoshihiro

AU - Kasai, Hiroko

AU - Yoshida, Tetsuya

AU - Saleh, Marwah A.

AU - Amagai, Masayuki

AU - Yamagami, Jun

PY - 2013/11

Y1 - 2013/11

N2 - Epidermolysis bullosa acquisita (EBA) is an autoimmune subepidermal blistering disease caused by autoantibodies against type VII collagen. An enzyme-linked immunosorbent assay (ELISA) is currently available to detect autoantibodies in EBA. There have been reports suggesting generically that ELISA indices reflect EBA disease severity; however, there is, as yet, no conclusion as to whether ELISA indices fluctuate with disease activity over time in each EBA patient. This study aimed to investigate whether ELISA titers fluctuate with EBA disease activity and to validate the clinical significance of checking ELISA values in EBA by monitoring type VII collagen ELISA titers and disease severity, evaluated in terms of numbers of blisters and erosions as a clinical score, over time in three Japanese patients with EBA. All three cases in this study, which were treated successfully, showed titers of anti-type VII collagen autoantibodies detected by ELISA that fluctuated in parallel with disease activity. Especially in case 1, we could determine that the expanding erosions were not due to flare-ups of EBA because the ELISA indices stayed low, although new lesions continued to appear. In fact, control of infection and nutrition helped the lesions to become epithelialized. In conclusion, we found that repeated ELISA measurements are useful in monitoring disease activity and making decisions in EBA treatment plans.

AB - Epidermolysis bullosa acquisita (EBA) is an autoimmune subepidermal blistering disease caused by autoantibodies against type VII collagen. An enzyme-linked immunosorbent assay (ELISA) is currently available to detect autoantibodies in EBA. There have been reports suggesting generically that ELISA indices reflect EBA disease severity; however, there is, as yet, no conclusion as to whether ELISA indices fluctuate with disease activity over time in each EBA patient. This study aimed to investigate whether ELISA titers fluctuate with EBA disease activity and to validate the clinical significance of checking ELISA values in EBA by monitoring type VII collagen ELISA titers and disease severity, evaluated in terms of numbers of blisters and erosions as a clinical score, over time in three Japanese patients with EBA. All three cases in this study, which were treated successfully, showed titers of anti-type VII collagen autoantibodies detected by ELISA that fluctuated in parallel with disease activity. Especially in case 1, we could determine that the expanding erosions were not due to flare-ups of EBA because the ELISA indices stayed low, although new lesions continued to appear. In fact, control of infection and nutrition helped the lesions to become epithelialized. In conclusion, we found that repeated ELISA measurements are useful in monitoring disease activity and making decisions in EBA treatment plans.

KW - autoantibody

KW - clinical severity

KW - enzyme-linked immunosorbent assay

KW - epidermolysis bullosa acquisita

KW - type VII collagen

UR - http://www.scopus.com/inward/record.url?scp=84886950750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886950750&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.12278

DO - 10.1111/1346-8138.12278

M3 - Article

C2 - 24127822

AN - SCOPUS:84886950750

VL - 40

SP - 864

EP - 868

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 11

ER -